Company: LHI
Filing Date: 2025-08-08
Form Type: F-1/A
Source: 0001213900-25-073646
Chunk: 239

Company: Living Homeopathy International Ltd.
Filing Date: 2025-08-08
Form: F-1/A
Chunk 239
---
 of the Group.

Living Homeopathy Global Ltd. (“Living
Global”), a British Virgin Islands (“BVI”) company limited by shares incorporated on May 27, 2024 and a wholly owned
subsidiary controlled by the Company, is the immediate holding company of Living HK, a company incorporated in Hong Kong with limited
liability on June 21, 1994 and the Group’s operating subsidiary in Hong Kong.

Prior to the reorganization described below,
Living HK was direct wholly-owned and controlled by Mr. Ka Lun To (“Mr. To”), the controlling shareholder.

In connection with its proposed initial public
offering, the Company undertook a reorganization of its legal structure (the “Reorganization”). The Reorganization involved:

| (i) | On May 7, 2024, the Company was incorporated in the Cayman Islands                                                                          
 with limited liability and authorized share capital of $50,000 divided into 50,000 of a par value of $1 each. On its date of incorporation, 
 the Company allotted and issued 1 share to LTO Holdings Ltd. (“LTO”), a company controlled by Mr. To.                                       |

| (ii) | On                                                                                                    
 May 27, 2024, Living Global was incorporated in BVI with limited liability and authorized             
 share capital of $50,000 divided into 50,000 of a par value of $1 each. On its date of incorporation, 
 Living Global allotted and issued 1 share to the Company at $1. Upon completion of such allotment     
 and issue of share of Living Global to the Company, Living Global became a direct wholly-owned        
 subsidiary of the Company.                                                                            |

| (iv) | On                                                                                               
 August 28, 2024, a shareholder resolution was passed and approved and the article of association 
 of the Company was amended that (i) the number of authorized shares increased from 50,000        
 shares to 500,000,000 shares and divided into 450,000,000 Class A Ordinary Shares and 50,000,000 
 Class B Ordinary Shares; and (ii) the par value of the shares decreased from $1 each to $0.0001  
 each (collectively refer as the “Share Re-classification”). One Class A                          
 Ordinary Share represents one voting right and one Class B Ordinary Share represents fifteen     
 voting rights. The authorized share capital of the Company remained unchanged at $50,000.        
 The 1 issued ordinary share held by LTO